BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CEACAM5, CEA AND Treatment
240 results:

  • 1. Initial presentation of hepatocellular carcinoma as pharyngeal mass mimicking advanced hypopharyngeal carcinoma.
    Sukumaran R; Kattoor J; Valsalamony J; Varghese BT
    J Cancer Res Ther; 2024 Jan; 20(1):438-440. PubMed ID: 38554358
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
    Perrier L; Balusson F; Morelle M; Castelli J; Thariat J; Benezery K; Hasbini A; Gery B; Berger A; Liem X; Guihard S; Chapet S; Thureau S; Auberdiac P; Pommier P; Ruffier A; Devillers A; Oger E; Campillo-Gimenez B; de Crevoisier R
    Radiother Oncol; 2024 Apr; 193():110116. PubMed ID: 38316193
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Carotid endarterectomy for the management of carotid stenosis occurring concurrently with head and neck cancer.
    Telischi J; Nisenbaum E; Nicolli E
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):452-456. PubMed ID: 37916904
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of pretreatment FDG PET-CT for short-term efficacy of radioactive iodine-125 seed implantation in patients with NSCLC.
    Hu T; Shen J; Shao M; Feng X; Lu D; Ding E
    Brachytherapy; 2023; 22(6):882-888. PubMed ID: 37758577
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of neoadjuvant therapy on serum transforming growth factor-β, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer.
    Zhang R; Tian W; Zhao H; Zhang Z; Wu J; Sun S; Liu H
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):112-118. PubMed ID: 37571892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. First-line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta-analysis and cost-effectiveness analysis.
    Han J; Zeng N; Tian K; Liu Z; She L; Wang Z; He J; Chen N
    Head Neck; 2023 Sep; 45(9):2246-2258. PubMed ID: 37435624
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of safety and efficacy of autologous oral mucosa-derived epithelial cell sheet transplantation for prevention of anastomotic restenosis in congenital esophageal atresia and congenital esophageal stenosis.
    Fujino A; Fuchimoto Y; Mori T; Kano M; Yamada Y; Ohno M; Baba Y; Isogawa N; Arai K; Yoshioka T; Abe M; Kanai N; Takagi R; Maeda M; Umezawa A
    Stem Cell Res Ther; 2023 Apr; 14(1):86. PubMed ID: 37055850
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
    Yin L; Chen GL; Xiang Z; Liu YL; Li XY; Bi JW; Wang Q
    Biomed Pharmacother; 2023 Jun; 162():114648. PubMed ID: 37023621
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis.
    Nurczyk K; Nowak N; Carlson R; Skoczylas T; Wallner G
    Adv Med Sci; 2023 Mar; 68(1):138-146. PubMed ID: 36944288
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Other markers of medullary thyroid cancer, not only calcitonin.
    Censi S; Manso J; Mian C
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
    Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
    Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, treatment, and Follow-Up Strategy.
    Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
    Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
    Zhang J; Zhang J; Han J
    Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis.
    Zhu Y; Liu K; Wang K; Peng L
    Front Endocrinol (Lausanne); 2022; 13():909333. PubMed ID: 35909569
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response.
    Yang CK; Hsu HC; Liu YH; Tsai WS; Ma CP; Chen YT; Tan BC; Lai YY; Chang IY; Yang C; Yang CY; Yu JS; Liu H
    Cell Oncol (Dordr); 2022 Aug; 45(4):621-638. PubMed ID: 35849310
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society.
    Suzuki T; Yajima S; Okamura A; Yoshida N; Taniyama Y; Murakami K; Ohkura Y; Nakajima Y; Yagi K; Fukuda T; Ogawa R; Hoshino I; Kunisaki C; Narumiya K; Tsubosa Y; Yamada K; Shimada H;
    Dis Esophagus; 2022 Dec; 35(12):. PubMed ID: 35661884
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prospective study on the clinical relevance of
    Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
    Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effects of Traditional Chinese Medicine Anticancer Decoction Combined with Basic Chemotherapy and Nursing Intervention on Oral cancer Patients after Surgery and Its Effect on Tumor Markers and Immune Function.
    Jiang D; Xiao F; Liu L; Meng Z; Zhang C
    Biomed Res Int; 2022; 2022():6341381. PubMed ID: 35402612
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.